Sutro Biopharma, Inc. (STRO)
16.38
+0.76
(+4.87%)
USD |
NASDAQ |
Feb 13, 14:11
Sutro Biopharma Free Cash Flow : -225.11M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GT Biopharma, Inc. | -11.36M |
| Rhythm Pharmaceuticals, Inc. | -149.13M |
| Crinetics Pharmaceuticals, Inc. | -356.03M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.19M |
| Cash from Investing (Quarterly) | 39.99M |
| Cash from Financing (Quarterly) | 0.102M |
| Free Cash Flow Per Share (Quarterly) | -4.529 |
| Free Cash Flow to Equity (Quarterly) | -46.30M |
| Free Cash Flow to Firm (Quarterly) | -28.77M |
| Free Cash Flow Yield | -50.76% |